RankingsPricing
  1. US-listed companies
  2. BOSTON SCIENTIFIC CORP
  3. Financials
  4. Cash from financing

BOSTON SCIENTIFIC CORPBSX

Market cap
$143.3B
P/E ratio
SummaryFinancials
Period EndCash from financing (Million USD)YoY (%)
Dec 31, 20241,814+36180.00%
Dec 31, 20235-100.91%
Dec 31, 2022-548+476.84%
Dec 31, 2021-95-132.42%
Dec 31, 2020293-90.14%
Dec 31, 20192,973+107.61%
Dec 31, 20181,432+1201.82%
Dec 31, 2017110-153.40%
Dec 31, 2016-206-115.58%
Dec 31, 20151,322-981.33%
Dec 31, 2014-150-74.83%
Dec 31, 2013-596-19.89%
Dec 31, 2012-744-56.77%
Dec 31, 2011-1,721+246.98%
Dec 31, 2010-496

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)